SBMFF US EQUITY Health Care Health Care CIK: 1604982

Sino Biopharmaceutical Limited/ADR (SBMFF) Quant Factor Diagnostic & Fair Value Model

Sino Biopharmaceutical Limited/ADR (Ticker: SBMFF) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$0.67

0.00% Latest Close (2026-10-23)

Market Cap: $11.84B

P/E Ratio: 34.1

Momentum Strength 3M / 12M

+4.40%

1M: -4.32% 12M: -28.19%

Quality (ROE) Point-in-Time

Trailing Return on Equity

Technical Trend RSI 14

0.0

SMA50: $0.70 SMA200: $0.72

Valuation Multiplier Trailing

34.1

Premium Multiple (> 30x P/E)

📊 Valuation & Multi-Factor Diagnostic

Premium Multiple (> 30x P/E)

SBMFF trades at 34.1x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 3/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1604982 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1604982

💡 Methodology & Frequently Asked Questions

Key reference details regarding Sino Biopharmaceutical Limited/ADR (SBMFF) valuation multiples, momentum factors, and point-in-time filing conventions.

How should SBMFF's current valuation multiple be interpreted? ↓

SBMFF trades at a trailing P/E of 34.1x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are SBMFF's key momentum and technical factor indicators? ↓

As of the latest close, SBMFF shows a 1-month return of -4.32%, 3-month return of +4.40%, and 12-month return of -28.19%, with a 14-day RSI of 0.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for SBMFF? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can SBMFF be incorporated into systematic factor models? ↓

SBMFF can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.